Cargando…

Dual-Targeted Therapy in HER2-Overexpressing Breast Cancer with Trastuzumab and Novel Cholesterol-Based Nioplexes Silencing Mcl-1

The challenge in HER2-overexpressing breast cancer therapy lies in creating an effective target therapy to overcome treatment resistance. Monoclonal antibodies and target gene silencing by siRNA are two potential strategies that have been widely developed for treating HER2-positive breast cancer. Th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pengnam, Supusson, Opanasopit, Praneet, Rojanarata, Theerasak, Yingyongnarongkul, Boon-ek, Thongbamrer, Chopaka, Plianwong, Samarwadee
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10610066/ https://www.ncbi.nlm.nih.gov/pubmed/37896184 http://dx.doi.org/10.3390/pharmaceutics15102424

Ejemplares similares

Synergistic Effect of Doxorubicin and siRNA-Mediated Silencing of Mcl-1 Using Cationic Niosomes against 3D MCF-7 Spheroids
por: Pengnam, Supusson, et al.
Publicado: (2021)

siRNA Targeting Mcl-1 Potentiates the Anticancer Activity of Andrographolide Nanosuspensions via Apoptosis in Breast Cancer Cells
por: Pengnam, Supusson, et al.
Publicado: (2022)

Chitosan Combined with Poly-L-arginine as Efficient, Safe, and Serum-Insensitive Vehicle with RNase Protection Ability for siRNA Delivery
por: Plianwong, Samarwadee, et al.
Publicado: (2013)

Characterization and In Vitro Skin Permeation of Meloxicam-Loaded Liposomes versus Transfersomes
por: Duangjit, Sureewan, et al.
Publicado: (2011)

Mechanistic study of decreased skin penetration using a combination of sonophoresis with sodium fluorescein-loaded PEGylated liposomes with d-limonene
por: Rangsimawong, Worranan, et al.
Publicado: (2015)

Type and composition of surfactants mediating gene transfection of polyethylenimine-coated liposomes
por: Opanasopit, Praneet, et al.
Publicado: (2011)

Investigation of the mechanism of enhanced skin penetration by ultradeformable liposomes
por: Subongkot, Thirapit, et al.
Publicado: (2014)

Influence of nanofiber alignment on the release of a water-soluble drug from cellulose acetate nanofibers
por: Patrojanasophon, Prasopchai, et al.
Publicado: (2020)

Preactivated-thiolated polyacrylic acid/1-vinyl pyrrolidone nanoparticles as nicotine carriers for smoking cessation
por: Pornpitchanarong, Chaiyakarn, et al.
Publicado: (2020)

The development of poly-L-arginine-coated liposomes for gene delivery
por: Opanasopit, Praneet, et al.
Publicado: (2011)

A combined approach of hollow microneedles and nanocarriers for skin immunization with plasmid DNA encoding ovalbumin
por: Pamornpathomkul, Boonnada, et al.
Publicado: (2017)

Formulation and Optimal Design of Dioscorea bulbifera and Honey-Loaded Gantrez(®)/Xyloglucan Hydrogel as Wound Healing Patches
por: Eakwaropas, Pattaranut, et al.
Publicado: (2022)

Role of the charge, carbon chain length, and content of surfactant on the skin penetration of meloxicam-loaded liposomes
por: Duangjit, Sureewan, et al.
Publicado: (2014)

Development and Evaluation of Novel Water-Based Drug-in-Adhesive Patches for the Transdermal Delivery of Ketoprofen
por: Arunprasert, Kwanputtha, et al.
Publicado: (2021)

Synthesis of Polyethylene Glycol Diacrylate/Acrylic Acid Nanoparticles as Nanocarriers for the Controlled Delivery of Doxorubicin to Colorectal Cancer Cells
por: Myat, Yin Yin, et al.
Publicado: (2022)

Ethanolic Extract of Ocimum sanctum Leaves Reduced Invasion and Matrix Metalloproteinase Activity of Head and Neck Cancer Cell Lines
por: Utispan, Kusumawadee, et al.
Publicado: (2020)

Apis mellifera propolis enhances apoptosis and invasion inhibition in head and neck cancer cells
por: Niyomtham, Nattisa, et al.
Publicado: (2021)

Ethanolic extract of Ocimum sanctum leaf modulates oxidative stress, cell cycle and apoptosis in head and neck cancer cell lines
por: Utispan, Kusumawadee, et al.
Publicado: (2023)

Clausmarin A, Potential Immunosuppressant Revealed by Yeast-Based Assay and Interleukin-2 Production Assay in Jurkat T Cells
por: Suauam, Pitipreya, et al.
Publicado: (2015)

The Oral Wound Healing Potential of Thai Propolis Based on Its Antioxidant Activity and Stimulation of Oral Fibroblast Migration and Proliferation
por: Jongjitaree, Suppanut, et al.
Publicado: (2022)

ANKRD44 Gene Silencing: A Putative Role in Trastuzumab Resistance in Her2-Like Breast Cancer
por: La Ferla, Marco, et al.
Publicado: (2019)

Epigenetic Silencing of HER2 Expression during Epithelial-Mesenchymal Transition Leads to Trastuzumab Resistance in Breast Cancer
por: Nami, Babak, et al.
Publicado: (2021)

Development of Ultradeformable Liposomes with Fatty Acids for Enhanced Dermal Rosmarinic Acid Delivery
por: Subongkot, Thirapit, et al.
Publicado: (2021)

Erratum: ANKRD44 Gene Silencing: A Putative Role in Trastuzumab Resistance in Her2-Like Breast Cancer
Publicado: (2019)

Effect of Trastuzumab–HER2 Complex Formation on Stress-Induced Modifications in the CDRs of Trastuzumab
por: Spanov, Baubek, et al.
Publicado: (2022)

Cellular transport of anti-inflammatory pro-drugs originated from a herbal formulation of Zingiber cassumunar and Nigella sativa
por: Tangyuenyongwatana, Prasan, et al.
Publicado: (2009)

Optimal Design of Novel Microemulsions-Based Two-Layered Dissolving Microneedles for Delivering Fluconazole in Treatment of Fungal Eye Infection
por: Suriyaamporn, Phuvamin, et al.
Publicado: (2022)

Topical Film-Forming Chlorhexidine Gluconate Sprays for Antiseptic Application
por: Chamsai, Benchawan, et al.
Publicado: (2022)

Targeting transcription of MCL-1 sensitizes HER2-amplified breast cancers to HER2 inhibitors
por: Floros, Konstantinos V., et al.
Publicado: (2021)

HER2 therapy: Molecular mechanisms of trastuzumab resistance
por: Nahta, Rita, et al.
Publicado: (2006)

Targeting HER2 in breast cancer: beyond trastuzumab
por: Winer, EP
Publicado: (2011)

Quantification of Trastuzumab–HER2 Engagement In Vitro and In Vivo
por: Rudkouskaya, Alena, et al.
Publicado: (2020)

Epigenetic silencing of miR-375 induces trastuzumab resistance in HER2-positive breast cancer by targeting IGF1R
por: Ye, Xing-Ming, et al.
Publicado: (2014)

Cost-effectiveness analysis of trastuzumab deruxtecan versus trastuzumab emtansine for HER2-positive breast cancer
por: Yang, Jiangping, et al.
Publicado: (2022)

A Novel Approach for Skin Regeneration by a Potent Bioactive Placental-Loaded Microneedle Patch: Comparative Study of Deer, Goat, and Porcine Placentas
por: Tansathien, Kritsanaporn, et al.
Publicado: (2022)

Conessine as a novel inhibitor of multidrug efflux pump systems in Pseudomonas aeruginosa
por: Siriyong, Thanyaluck, et al.
Publicado: (2017)

Cardiotoxicity of trastuzumab in patients with HER2-positive gastric cancer
por: Soo Park, Ji, et al.
Publicado: (2017)

Cryo-EM Structure of HER2-trastuzumab-pertuzumab complex
por: Hao, Yue, et al.
Publicado: (2019)

Addition of GM-CSF to trastuzumab stabilises disease in trastuzumab-resistant HER2+ metastatic breast cancer patients
por: Cheng, Y C, et al.
Publicado: (2010)

Neoadjuvant PF-05280014 (a potential trastuzumab biosimilar) versus trastuzumab for operable HER2+ breast cancer
por: Lammers, Philip E., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_svqkd7tp3qcrt6ls6t3sus618r